Introduction
============

COPD is a global public health concern that causes significant morbidity and mortality with an increasing trend.[@b1-copd-13-2751] In 2011, age and gender standardized national prevalence rates of COPD in Turkey were reported to be 5.3% and 4.0%, respectively, when the disease was diagnosed based on pulmonary function tests (PFTs) and physicians' assessments.[@b2-copd-13-2751] Owing to the discordance between these two rates, a practice pattern study (ALPHABET) was conducted to examine how COPD patients were evaluated in real life.[@b3-copd-13-2751] The ALPHABET study showed that the ratio of forced expiratory volume in 1 second (FEV~1~) to forced vital capacity was ≥70% in 40% of the patients previously diagnosed with COPD. Besides, the most common treatment regimen, which was used in 62% of COPD patients, was triple therapy, ie, the combination of long-acting β2 agonists (LABA), inhaled corticosteroids (ICS), and long-acting muscarinic antagonists (LAMA).[@b3-copd-13-2751] The same study also showed that physicians' compliance to multidimensional assessment approach, as outlined by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) strategy, was relatively low. In a study from the United States including the records of 450 patients with COPD confirmed by spirometry, it was demonstrated that 43.6% of the patients were not receiving guideline-based treatment and, of these patients, who were all GOLD stage I, 7.6% were overtreated.[@b4-copd-13-2751] Moreover, another study from the United States reported that 23.1% of the COPD patients received a treatment that was not consistent with any of the guidelines' recommendations irrespective of disease severity.[@b5-copd-13-2751] Based on these findings, the current study, which was called "WHY Study", was designed to evaluate attitudes of physicians regarding COPD diagnosis, treatment, and follow-up and to identify the factors influencing physicians' decisions in clinical practice.

Patients and methods
====================

The present study was designed as a practice pattern survey and conducted from April to July 2015. The study was approved by the ethics committee of Dokuz Eylul University Medical Faculty (date: December 18, 2014; no: 2014/37-02). Written and signed informed consents of the physicians to participate in the study were obtained.

No actual patients were enrolled; however, fictitious case scenarios were used to represent patients with COPD. For each case scenario, demographic features, medical histories, physical examination findings, and medical and screening test results were prepared prior to the study.

Fifty physicians who were working in different tertiary (university hospitals or training and research hospitals) and secondary (state hospital or private hospital) health care centers and willing to participate in the study were included. The centers were selected from 12 provinces (Adana, Ankara, Samsun, Balikesir, Trabzon, Bursa, Izmir, Gaziantep, Istanbul, Erzurum, Kayseri, and Van) according to the European Community Regional Policies Level 2 Statistical Regional Units (EuroStat NUTS 2 regions) to provide a representative sample of Turkey. In Turkey, the tertiary health care centers are also academic centers, which have residency programs and train pulmonology fellows. These consist of university hospitals and a total of four research and training hospitals for pulmonary diseases. The secondary health care centers are state hospitals, which only provide patient care.

Case scenarios
--------------

All scenarios and related documents were produced by the steering committee of the study based on the recommendations of the GOLD document and the Turkish Thoracic Society's COPD guideline, similar to the methodology used by Fukuhara et al.[@b6-copd-13-2751] The members of the committee were physicians with a special interest in COPD, working as consultants in academic institutions. The participants were expected to order the correct diagnostic tests, to evaluate the quality of the spirometry, to use the right parameters (level of FEV~1~, symptom score, and history of exacerbations) for classifying the patient, and to choose a treatment regimen that was concordant with the guidelines.

The following five scenarios described patients with COPD: Case GOLD A-smoker and Case GOLD A-nonsmoker were previously undiagnosed patients presenting with dyspnea, Case GOLD D-smoker and GOLD B-exsmoker were COPD patients presenting with exacerbation, Case GOLD B-smoker was a previously diagnosed COPD patient with dyspnea in stable phase. The remaining two cases, which are sometimes misdiagnosed and/or treated as COPD, were Case asthma-COPD overlap syndrome (ACOS) and Case obesity hypoventilation syndrome (OHS). Each case scenario included the results of medical and screening tests that are usually used in clinical practice for diagnosing COPD patients. Detailed description of the case scenarios is presented in [Table S1](https://www.dovepress.com/get_supplementary_file.php?f=154616.pdf).

The same PFT result sheet was used for all COPD cases. However, Case ACOS and Case OHS had distinctive PFT result sheets. In some cases, some tricky PFT results, compatible with a noncooperative patient, were first given to the physicians, expecting them to request an acceptable PFT result sheet. Similarly, chest X-rays of poor technical quality were also given. Thus, a patient dossier was prepared for each case scenario.

During face-to-face interviews, physicians examined the history and laboratory and radiographic findings and requested additional tests, whenever they felt a need, until they reached a decision for each of the seven case scenarios ([Table 1](#t1-copd-13-2751){ref-type="table"}). In these interviews, the GOLD classification of the cases was not asked to the physicians; however, they were evaluated by checking whether they asked for the correct clinical parameters to classify the patients, namely symptom scores, history of exacerbations, and FEV~1~ levels.

The tests requested by the physicians were recorded. There was no limitation in time for the physicians to review the cases in detail. If the physicians required more tests for decision making, the results of all required tests were given and were also recorded. Physicians were also asked to complete the "Physician Questionnaire" that included questions about their institutions, number of patients they examine in routine daily practice, years of working as a clinician, whether PFT and chest X-rays were performed in their institution, his/her routine procedures to examine a new COPD patient, and whether he/she routinely used a questionnaire to assess the symptoms and/or health-related quality of life of patients. All questionnaires were collected by the interviewers and transferred to the study center for data management.

Statistical analyses
--------------------

Predictive Analytics Software for Windows Version 18.0 (SPSS Inc., Chicago, IL, USA) was used for statistical analysis. In descriptive statistics, categorical variables were expressed as numbers and percentages and numerical variables were expressed as median (minimum--maximum). Two-group comparisons between categorical variables were performed using the Chi-square test or the Fisher's exact test, as required. The Spearman's rho test statistics was used in correlations for non-normal distributed numerical data. Multivariate logistic regression analysis was performed to determine the factors affecting the guideline-concordant diagnosis. Statistical significance level was set at a *P*-value of \<0.05.

Results
=======

Of the 50 physicians included in the study, 31 (62%) physicians were working in a tertiary health care center and the remaining 19 physicians were working in a secondary health care center. The median number of years worked as a specialist was 7 years (range, 1--33 years), and 65.3% of the physicians had been working as a specialist for ≤10 years. The median number of patients examined daily by the physicians was 40 (range, 8--90). Spirometry was available in all institutions. Features of the physicians are summarized in [Table 2](#t2-copd-13-2751){ref-type="table"}.

While 44% (n=22) of the physicians performed guideline-concordant diagnosis in the five COPD cases, only 6% (n=3) of the physicians performed guideline-concordant diagnosis in all seven cases ([Table 3](#t3-copd-13-2751){ref-type="table"}). There was a negative correlation between the workload (≥40 patient examinations per day) of the physicians and the likelihood of making a guideline-concordant diagnosis (*P*=0.038, rho =−0.417). There was no relationship between a guideline-concordant diagnosis and the working place (tertiary or secondary health care center) as well as the number of years worked as a specialist (*P*\>0.05, for both). In multivariate logistic regression analysis performed to determine the factors (including gender, number of years working as a specialist, working place \[secondary or tertiary health care center\], and number of patients examined daily) affecting the guideline-concordant diagnosis, working in a tertiary health care center was found to be the only significant factor in favor of establishing a guideline-concordant diagnosis of COPD (*P*=0.029, OR =6.139 \[95% CI: 1.20--31.32\]).

Independently from failures in the diagnosis and categorization of COPD patients, guideline-concordant treatment rates were 20%, 46%, 84%, 20%, 18%, and 24% in Cases GOLD A-smoker, GOLD A-nonsmoker, GOLD D-smoker, GOLD B-exsmoker, GOLD B-smoker, and ACOS, respectively. The guideline-concordant treatment rates for guideline-concordant diagnosed and categorized patients were 4%, 6%, 4%, 2%, and 2% in Cases GOLD A-smoker, GOLD A-nonsmoker, GOLD D-smoker, GOLD B-exsmoker, GOLD B-smoker, and ACOS, respectively. While the lowest rates for guideline-concordant diagnosis and guideline-concordant treatment were seen in Case GOLD A-smoker and Case ACOS, Case GOLD D-smoker was associated with the highest rates of correct answers ([Table 3](#t3-copd-13-2751){ref-type="table"}) (details are presented in [Table S2](https://www.dovepress.com/get_supplementary_file.php?f=154616.pdf)).

The rate of guideline-concordant diagnosis among physicians who used appropriate PFT was 38% in Case GOLD A-smoker, whereas the rates increased to 74%, 78%, 80%, and 82% in Case GOLD A-nonsmoker, Case GOLD D-smoker, Case GOLD B-exsmoker, and Case GOLD B-smoker, respectively. However, even when a guideline-concordant diagnosis of COPD was made, only a minority of the physicians (10--24%) used the GOLD classification and gave guideline-concordant treatment ([Figure 1](#f1-copd-13-2751){ref-type="fig"}).

Discussion
==========

The present study evaluated the physicians' behaviors on COPD management using fictitious case scenarios and showed that the patients' characteristics influenced the physicians' decision making. This influence was more apparent in newly diagnosed patients. The classification of the cases according to the GOLD 2015 criteria was also problematic. Besides, correct parameters were used by 10%--24% of the physicians and correct classification was performed only by 2%--6%. Moreover, only 4--7 of the physicians used the correct tools for decision making. In spite of the problems in the classification, 18%--84% of the physicians prescribed the appropriate treatment.

Although Case GOLD A-smoker and Case GOLD A-nonsmoker were newly diagnosed patients, they differed in age and smoking status, which might have led to different rates in guideline-concordant diagnosis (38% vs 74%). In contrast, Case ACOS was concordantly diagnosed by a higher proportion of the physicians. Case OHS was previously misdiagnosed and treated as COPD and was concordantly diagnosed only by eight physicians. Thus, a previous diagnosis of COPD appears to mislead the physicians to continue with the same mistake. Each new encounter should give the physicians a chance to re-evaluate their patients.

The distribution of COPD patients among the GOLD categories has been evaluated by several studies. The proportion of cases in GOLD A category is roughly between 30% and 40%.[@b7-copd-13-2751]--[@b9-copd-13-2751] The national ALPHABET study reported that GOLD A and D were the two most prevalent COPD categories, comprising 41.1% and 25.0% of the patients regularly seen at secondary and tertiary health care centers.[@b3-copd-13-2751] As these were the most common categories, physicians are expected to diagnose and manage such patients appropriately in accordance with the GOLD guidelines. However, the rates of guideline-concordant diagnosis and treatment were low, possibly due to the tendency of physicians to make decisions based on their clinical experience, particularly in these low-risk groups with lesser symptoms.[@b3-copd-13-2751] In a multicenter study conducted on 4,094 patients in Italy to investigate whether pulmonologists follow the GOLD guidelines in prescribing COPD treatment, they reported that 62.1% of the patients were receiving inappropriate treatment in accordance with the GOLD recommendations.[@b10-copd-13-2751] In a study conducted to investigate the rates of adherence to GOLD 2010 guidelines for COPD treatment among pulmonologists in Turkey, overall adherence to GOLD recommendations was 59.5%.[@b11-copd-13-2751] In another study from Turkey, adherence to guideline recommendations for COPD patients was found to be 48.2%.[@b12-copd-13-2751] In the present study as well, the rate of guideline-concordant diagnosis among physicians who used appropriate PFT was 38% in Case GOLD A-smoker, while the rates increased to 74%, 78%, 80%, and 82% in Case GOLD A-nonsmoker, Case GOLD D-smoker, Case GOLD B-exsmoker, and Case GOLD B-smoker, respectively. However, even if the guideline-concordant diagnosis of COPD was performed, only a minority (10%--24%) of the physicians used the GOLD classification.

The diagnosis of COPD should be based on the evaluation of PFTs; however, several previous studies which evaluated the practice patterns of physicians to diagnose COPD have shown that clinical experience has a significant impact on diagnosis and frequently replaces spirometry. An Italian study reported that for patients examined by general practitioners, the COPD diagnosis was based on the physicians' decisions in 30%.[@b13-copd-13-2751] Similarly, another study from Tasmania reported that 30% of the patients diagnosed with COPD had no spirometric evaluation.[@b14-copd-13-2751] Moreover, a Chinese study reported that 64.3% of the hospitals lacked spirometers for COPD diagnosis.[@b15-copd-13-2751] A more recent study from China also reported that knowledge about COPD was fairly low among general practitioners.[@b16-copd-13-2751] In a multinational study including centers from the Europe and the United States, 24% of the COPD patients reported that they had not undergone a spirometry test.[@b17-copd-13-2751] As can be seen from different population examples, PFTs are not always incorporated in the diagnosis and management of COPD in several parts of the world. The present study showed that spirometry was frequently overlooked in clinical practice in Turkey and that the physicians had problems in interpreting the results when it was performed.

It thus appears that despite educational efforts including scientific meetings, webinars, and national guidelines, important issues remain in the diagnosis and guideline-concordant management of COPD patients in Turkey. There is a strong need to re-evaluate the effectiveness of the current educational tools, to assess clinicians' needs, and to focus more on improving the practice and clinical behavior of pulmonologists caring for COPD patients.

Another interesting finding was the relationship between workload and guideline-concordant diagnosis. The median number of patients examined by the physicians was found to be 40 per day, and with a rough calculation, the physicians had only 12 minutes per patient for examination and decision making. The workload was particularly higher in state hospitals. A recent study by Musellim et al,[@b18-copd-13-2751] however, suggested that in pulmonary practice, the average time allocated to each patient should be 20 minutes and that physicians should spare 25 minutes for patients with chronic lung disorders. In reality, however, under time constraints for each patient, physicians appear to depend more heavily on their clinical experience and possibly use preconceived templates in the evaluation and management of COPD patients. This lack of objective and individual assessment may be another explanation for the low rates of guideline-concordant diagnosis.

One of the limitations of the present study was the use of fictitious cases, which might not reflect real-life practices. However, in order to better evaluate the practice patterns, standard questions on standard clinical problems had to be directed to the physicians. Besides, the findings may be an underestimation of the problem, because the physicians would be less likely to make objective and individualized assessments of patients and be more prone to act on their reflexes due to serious time constraints and several distracting factors in the real-life setting. Another limitation could be the relatively low number of participants, which may raise concerns regarding the generalizability of the findings to the Turkish pulmonologist population. However, each participating physician was from a different medical center and each center was chosen from different provinces according to the EuroStat NUTS 2 regions and, thus, the present study population should be a representative sample.

Conclusion
==========

To the best of our knowledge, this is the first study that evaluated the physicians' behaviors in the process of diagnosis, treatment, and follow-up of COPD. The results of the present study revealed that the management of COPD patients in Turkey was not in accordance with the GOLD recommendations and was rather based on the physicians' clinical experience. This appeared to be related to heavy workload. Therefore, medical associations and professional societies should put more efforts for advocacy to decrease patient burden on physicians and to improve the quality of patient care. Besides, more work needs to be done both to raise awareness of physicians on evidence-based management of COPD patients and to reflect this knowledge in their clinical practice. There is a need for further studies evaluating the effects of educational interventions on physicians' knowledge and behavior.
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![Rate of guideline-concordant diagnosis and treatment decisions of the physicians according to case scenarios.\
**Abbreviations:** ACOS, asthma--COPD overlap syndrome; GOLD, Global Initiative for Chronic Obstructive Lung Disease.](copd-13-2751Fig1){#f1-copd-13-2751}

###### 

Details of seven case scenarios

  Case scenarios                                                    Similar history and findings   Case ACOS        Case OHS                                                                                                                                                                                                                                    
  ----------------------------------------------------------------- ------------------------------ ---------------- ---------------------------------------------------------- ---------------------------------------------------------- ---------------------------------------------------------- ---------------------------------------------------------- ----------------------------------------------------------
  **Scenario prepared by steering committee**                                                                                                                                                                                                                                                                                                                   
  Age (years)                                                       38                             63               57                                                         54                                                         61                                                         47                                                         79
  Gender                                                            Female                         Female           Female                                                     Male                                                       Male                                                       Male                                                       Female
  Smoking history                                                   Current smoker                 Never smoked     Current smoker                                             Quitted                                                    Current smoker                                             Quitted                                                    Passive smoker
  20 pack-years                                                     NA                             40 pack-years    40 pack-years                                              45 pack-years                                              28 pack-years                                              NA                                                         
  Comorbidity                                                       None                           None             None                                                       None                                                       Diabetes + Hypertension                                    None                                                       None
  Cancer                                                            None                           None             None                                                       None                                                       None                                                       None                                                       None
  Presenting with                                                   Breathlessness                 Breathlessness   Exacerbation                                               Exacerbation                                               Breathlessness                                             ACOS                                                       OHS
  FEV (%)                                                           55                             55               55                                                         55                                                         55                                                         55                                                         40
  FEV~1~/FVC (%)                                                    69                             69               69                                                         69                                                         69                                                         65                                                         88
  Previous diagnosis                                                Undiagnosed                    Undiagnosed      COPD                                                       COPD                                                       COPD                                                       Asthma-like history                                        COPD
  Time since diagnosis                                              NA                             NA               7 years                                                    7 years                                                    7 years                                                    Intermittent symptoms                                      10 years
  Hospitalization during the preceding year                         NA                             NA               Once due to COPD                                           Once due to COPD                                           Once due to COPD                                           None                                                       Once due to COPD
  Treatment                                                         NA                             NA               LABA and LAMA and ICS                                      LABA and LAMA and ICS                                      LABA and LAMA and ICS                                      LABA and ICS                                               LABA and LAMA and ICS
  Treatment compliance                                              NA                             NA               Compliance ±[a](#tfn1-copd-13-2751){ref-type="table-fn"}   Compliance ±[a](#tfn1-copd-13-2751){ref-type="table-fn"}   Compliance ±[a](#tfn1-copd-13-2751){ref-type="table-fn"}   Compliance -[b](#tfn2-copd-13-2751){ref-type="table-fn"}   Compliance ±[a](#tfn1-copd-13-2751){ref-type="table-fn"}
  Guideline-concordant diagnosis (not indicated in case scenario)   COPD                           COPD             COPD                                                       COPD                                                       COPD                                                       ACOS[a](#tfn1-copd-13-2751){ref-type="table-fn"}           OHS[b](#tfn2-copd-13-2751){ref-type="table-fn"}
  GOLD category (not indicated in case scenario)                    GOLD group A                   GOLD group A     GOLD group D                                               GOLD group B                                               GOLD group B                                               NA                                                         NA

**Notes:**

Compliance ± means that the patient was not taking his/her medications regularly.

Compliance - means that the patients were taking his/her medications occasionally.

**Abbreviations:** ACOS, asthma--COPD overlap syndrome; FEV~1~, forced expiratory volume in 1 second; FVC, forced vital capacity; GOLD, Global Initiative for Chronic Obstructive Lung Disease; ICS, inhaled corticosteroids; LABA, long-acting β2 agonists; LAMA, long-acting muscarinic antagonists; OHS, obesity hypoventilation syndrome; NA, not applicable.

###### 

Features of the physicians

  Features                                           
  -------------------------------------------------- ------------------
  Gender                                             
   Female                                            34 (68.0)
   Male                                              16 (32.0)
  Number of years working as a specialist            7.0 (1.0--33.0)
  Number of physicians working as a specialist for   
   ≤10 years                                         32 (65.3)
   \>10 years                                        17 (34.7)
  Working place                                      
   Tertiary health care center                       31 (62.0)
   Secondary health care center                      19 (38.0)
  Number of patients examined daily                  40.0 (8.0--90.0)
  Workload of physicians                             
   ≥40 patient examinations per day                  25 (52.1)
   \<40 patient examinations per day                 23 (47.9)
  Performing PFT in the institutions                 50 (100.0)

**Note:** Data are presented as n (%) or median (minimum--maximum), where appropriate.

**Abbreviation:** PFT, pulmonary function test.

###### 

Summary of the results for each case

  Case scenarios                                                                                                               Similar history and findings   Case ACOS               Case OHS                                                                                        
  ---------------------------------------------------------------------------------------------------------------------------- ------------------------------ ----------------------- ----------------------- ----------------------- ----------------------- ----------------------- -------------------------------
  Features of the cases                                                                                                        Female, young                  Female, older           Female, middle age      Male, middle age        Male, older             Male, younger           Female, elder, passive smoker
  Decision                                                                                                                                                                                                                                                                            
   Guideline-concordant diagnosis[a](#tfn6-copd-13-2751){ref-type="table-fn"}                                                  44% of the physicians          74% of the physicians   91% of the physicians   93% of the physicians   96% of the physicians   30% of the physicians   16% of the physicians
   Guideline-concordant treatment (% of total 50 physicians)                                                                   20% of the physicians          46% of the physicians   84% of the physicians   20% of the physicians   18% of the physicians   24% of the physicians   NA
  Stepping approach to physicians' decision process                                                                                                                                                                                                                                   
   Assessment with acceptable PFT                                                                                              43/50 (86%)                    43/50 (86%)             43/50 (86%)             43/50 (86%)             43/50 (86%)             NA                      NA
   Guideline-concordant diagnosis (% of the physicians who used appropriate PFT)[a](#tfn6-copd-13-2751){ref-type="table-fn"}   19/43 (38%)                    37/43 (74%)             39/43 (78%)             40/43 (80%)             41/43 (82%)             NA                      NA
   Categorization of the case according to GOLD groups (% of patients who were concordantly diagnosed)                         5/19 (10%)                     10/37 (20%)             9/39 (18%)              12/40 (24%)             11/41 (22%)             NA                      NA
   Making correct categorization/grouping                                                                                      2/5 (4%)                       3/10 (6%)               2/9 (4%)                2/12 (4%)               1/11 (2%)               NA                      NA
   Guideline-concordant treatment                                                                                              2/2 (4%)                       3/3 (6%)                2/2 (4%)                1/2 (2%)                1/1 (2%)                NA                      NA
   Follow-up                                                                                                                   2 (4%)                         1 (2%)                  1 (2%)                  1 (2%)                  1 (2%)                  NA                      NA
   Recommendations                                                                                                             4 (8%)                         3 (6%)                  4 (8%)                  1 (2%)                  2 (4%)                  NA                      NA

**Note:**

The two rates may not be similar, as some physicians made a diagnosis with clinical findings only and did not use a correctly performed spirometry.

**Abbreviations:** ACOS, asthma--COPD overlap syndrome; GOLD, Global Initiative for Chronic Obstructive Lung Disease; OHS, obesity hypoventilation syndrome; PFT, pulmonary function test.
